Evidence-based Management of Lipid Disorders

Dr Maud N Vissers, Dr John JP Kastelein, Dr Erik S Stroes

$283.95 $241.15

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

TFM Publishing Ltd
08 December 2010

Gastroenterology

Practising evidence-based medicine necessarily depends on the clinician having access to the best evidence available, but in a fast-moving field, keeping up to date with the latest developments is a challenging prospect. In this new volume, leading experts focus on the most important clinical issues associated with the management of lipid disorders, evaluating and interpreting the evidence available to provide the reader with a reliable summary of our current knowledge.

Topics covered include therapeutical strategies for managing hereditary lipid disorders, including familial hypercholesterolemia, both in adults and children, and familial combined hypercholesterolemia. The authors also evaluate the evidence for a link between inflammatory disease and cardiovascular risk; the metabolic syndrome and the interconnections between dyslipidemias and diabetes. They also look at therapeutic challenges such as the management of patients who are statin resistant, and the control of lipid levels in those suffering renal insufficiency. Tables highlight important data, evidence from trial results and expert reports, and each section concludes with a series of key points that present a summary of evidence-based recommendations for best practice, graded according to the quality of that evidence.

Evidence-based Management of Lipid Disorders provides the busy clinician with a unique analysis of the data supporting current therapies and will help the reader formulate effective strategies for treating their own patients.

By: Dr Maud N Vissers, Dr John JP Kastelein, Dr Erik S Stroes
Imprint: TFM Publishing Ltd
Country of Publication: United Kingdom
Edition: New edition
Dimensions: Height: 241mm, Width: 171mm, Spine: 23mm
Weight: 1g
ISBN: 9781903378717
ISBN 10: 1903378710
Pages: 322
Publication Date: 08 December 2010
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

Lipoprotein metabolism: what do we know now?; The epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases; Are lifestyle modifications a successful means for controlling lipid levels in the long run?; What are the diagnostic and therapeutic strategies for hereditary hypo-and hypercholesterolaemia?; Does raising HDL protect against atherosclerosis?; How do we diagnose hypertriglyceridaemia in clinical practice and what are the consequences for treatment?; What is the optimal treatment of familial combined hypercholesterolaemia?; How should we manage lipid and lipoprotein disorders in children?; What is the role of dyslipidaemia in the metabolic syndrome and diabetes mellitus?; What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels?; Is there a link between chronic inflammatory diseases and cardiovascular risk?; What is the evidence for a physiological and pathogenic role of lipoprotein (a)?; How do we identify and treat sitosterolaemia?; How can we deal with inborn errors in cholesterol and bile acid biosynthesis?; Differential diagnosis of patients with tendon xanthomas; When should we fear for statin interactions?; What are the considerations in patients who are statin resistant?

Maud N Vissers PhD, Academic Medical Centre, Department of Vascular Medicine, University of Amsterdam, Amsterdam, The Netherlands John JP Kastelein MD PhD, Academic Medical Centre, Department of Vascular Medicine, University of Amsterdam, Amsterdam, The Netherlands Erik S Stroes MD PhD, Academic Medical Centre, Department of Vascular Medicine, University of Amsterdam, Amsterdam, The Netherlands

Reviews for Evidence-based Management of Lipid Disorders

Allen Chun has produced an opus that incorporates an impressive grasp of Hong Kong colonial history with ethnographic research in Hong Kong's New Territories. Unstructuring Chinese Society is likely to stimulate considerable discussion. <br>-Alan Smart of University of Calgary, Canada <br>

WIN $150 GIFT VOUCHERS: ALADDIN'S GOLD

Evidence-based Management of Lipid Disorders

Dr Maud N Vissers, Dr John JP Kastelein, Dr Erik S Stroes

$283.95 $241.15

Hardback

Reviews for Evidence-based Management of Lipid Disorders

See Also

Contact Abbeys

Contact Galaxy

Contact Language

Contact Us

About ABBEY'S